Last reviewed · How we verify
NCT04133129
Effects of HIIT on Metabolic Syndrome
NA trial testing Low Volume-High Intensity Interval Training in Dyslipidemias in 180 participants. Status unknown.
2 March 2020
Quick facts
| Lead sponsor | Coventry University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 180 |
| Start date | 1 November 2019 |
| Primary completion | 2 March 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Low Volume-High Intensity Interval Training
- Moderate Intensity Continuous Training
Conditions studied
- Dyslipidemias — all drugs for Dyslipidemias →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Sedentary Behavior — all drugs for Sedentary Behavior →
- Obesity — all drugs for Obesity →
Sponsor
Coventry University
Who can join
Adults 18 to 65, any sex, with Dyslipidemias or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project aims to find out the differences between two different types of structured training interventions have on the lipid profile of persons with diagnosed dyslipidemia. Each training intervention will last for 12 weeks. Subjects participating in the project will undergo a series of tests before and after the training intervention which will allow us to make conclusions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04133129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dyslipidemias
Currently open trials in the same condition.
- NCT07308314 — Taining Golden Lake Comprehensive Chronic Disease Management Initiative · recruiting
- NCT06526273 — PILI 'Āina Household · NA · recruiting
- NCT06797401 — Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia · Phase 2 · recruiting
- NCT06380322 — Military Health and Nutrition Examination Study · recruiting
- NCT06183307 — Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia · NA · recruiting
Other Coventry University trials
Trials by the same sponsor.
- NCT06377319 — Decision Support System for Diagnosis and Progression of Heart Failure · not yet recruiting
- NCT05409404 — The Effects of 8 Weeks Post Exercise Hot Water Immersion on Vascular and Cardiometabolic Health in Physically Inactive M · NA · completed
- NCT05059899 — Home-based Circuit Training for People With Intermittent Claudication · NA · completed
- NCT05492552 — Cardiovascular Function and Physical Activity in COVID-19 · NA · completed
- NCT05292287 — Remote Maintenance Cardiac Rehabilitation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04133129 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Coventry University
- Last refreshed: 21 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04133129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing